[Skip to Navigation]
November 2006

Heart Outcomes Prevention Evaluation–The Ongoing Outcomes Study, Vitamin E, and Age-Related Macular Degeneration

Arch Ophthalmol. 2006;124(11):1665. doi:10.1001/archopht.124.11.1665-a

In a recent editorial regarding the use of vitamin E for age-related macular degeneration, Chew and Clemons stated:

For these reasons, combined with little evidence from the meta-analysis of harm at the 400 IU/d dosage, we do not think there is increased risk of mortality associated with the AREDS [Age-Related Eye Disease Study] supplements that include 400 IU/d of vitamin E.1

Add or change institution